More than 25 billion spent on mental disorders in 2017 In the Netherlands, 25.1 billion euros were spent on the treatment of mental and behavioural disorders in 2017.
Lead exposure via tap water at times too high Tap water from old lead water pipes accounts for an important part of the total daily exposure to lead.
Environmental radioactivity in the Netherlands : Results in 2017 RIVM reports annually on the level of radioactivity that occurs under normal circumstances in the environment and food.
New environmental noise and health guidelines Exposure to environmental noise is expected to cause more health problems in the Netherlands. There is increasingly more noise, and new houses are being built closer to noise sources.
Residential Wood Burning Alert in unfavourable weather conditions As of this autumn, RIVM will advise against burning wood in unfavourable weather conditions and or poor air quality.
Building blocks for a definition of microplastics The Dutch National Institute for Public Health and the Environment, RIVM has described building blocks for a definition of microplastics.
Jacco Wallinga appointed extraordinary Professor at LUMC From 1 September, Jacco Wallinga will hold the chair in Mathematical Modelling of Infectious Diseases at the department of Medical Statistics and Bio-informatics of the Leiden University Medical Ce
Little incentive from pharmaceutical legislation to promote alternatives to animal testing Current pharmaceutical legislation does not impose any legal constraints on the use of alternatives to animal testing, but neither does it actively encourage the use of these alternatives.
Information about medicines more accessible to the user The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w
Average disease burden highest for invasive pneumococcal disease and influenza The average annual disease burden for the total Dutch population was highest for invasive pneumococcal disease and influenza.